
Norgine Ventures
Europe, Hillingdon, United Kingdom, Uxbridge'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Description
Norgine Ventures provides debt and debt-like financing to innovative, fast-growing companies.
Investor Profile
Norgine Ventures has made 27 investments, with 0 in the past 12 months and 59% as lead.
Stage Focus
- Series Unknown (44%)
- Debt Financing (22%)
- Series B (7%)
- Seed (7%)
- Convertible Note (7%)
- Post Ipo Debt (4%)
- Post Ipo Equity (4%)
- Series A (4%)
Country Focus
- France (19%)
- United Kingdom (15%)
- Spain (11%)
- The Netherlands (11%)
- United States (11%)
- Israel (11%)
- Germany (7%)
- Switzerland (4%)
- Sweden (4%)
- Denmark (4%)
Industry Focus
- Health Care
- Medical Device
- Medical
- Biotechnology
- Health Diagnostics
- Manufacturing
- Information Technology
- Life Science
- Computer
- Video
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.